Citadel Advisors - ALZAMEND NEURO INC ownership

ALZAMEND NEURO INC's ticker is ALZN and the CUSIP is 02262M308. A total of 20 filers reported holding ALZAMEND NEURO INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ALZAMEND NEURO INC
ValueSharesWeighting
Q1 2023$7,565
-64.8%
17,800
-53.2%
0.00%
Q4 2022$21,466
-36.9%
38,000
+31.9%
0.00%
Q3 2022$34,000
-75.4%
28,800
-81.9%
0.00%
Q2 2022$138,000
+25.5%
159,446
+78.4%
0.00%
Q1 2022$110,000
-75.3%
89,400
-61.9%
0.00%
Q4 2021$445,000
-11.5%
234,400
+43.3%
0.00%
Q3 2021$503,000163,6250.00%
Other shareholders
ALZAMEND NEURO INC shareholders Q3 2022
NameSharesValueWeighting ↓
RFG Advisory, LLC 250,000$270,0000.02%
TRUIST FINANCIAL CORP 2,314,907$2,755,0000.01%
DARK FOREST CAPITAL MANAGEMENT LP 11,344$13,0000.00%
Insight Wealth Strategies, LLC 10,000$9,0000.00%
BANK OF AMERICA CORP /DE/ 1,686$2,0000.00%
MONEY CONCEPTS CAPITAL CORP 250$00.00%
WELLS FARGO & COMPANY/MN 380$00.00%
NORTHERN TRUST CORP 42,911$51,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 45,523$54,0000.00%
View complete list of ALZAMEND NEURO INC shareholders